OPRX's Sharpe Ratio of -0.66 indicates that for each unit of volatility, it generates -0.66 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Jul 11, 2026).
Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets. For how to read this number and when it can mislead, see Sharpe Ratio Explained.
OPRX Sharpe Ratio Rank
OPRX ranks above 15.3% of all investments in our database based on Sharpe Ratio over the past 12 months, indicating weak returns relative to total risk taken. Securities are ranked from 0 (worst) to 100 (best).
What moves the rank
- Strong returns with low total volatility → Higher rank
- High volatility (both upside and downside) → Lower rank
- Consistent returns → Higher rank than volatile returns of same magnitude
- Sharp drawdowns increase volatility → Lower rank
What you can do with this information
- Weak risk-adjusted returns relative to category peers
- Evaluate whether this holding aligns with your risk-return objectives
- Consider reducing exposure or re-evaluating position size
- Review higher-ranked alternatives in the same category
OPRX Sharpe Ratio Market Positioning
The chart shows OPRX's Sharpe Ratio relative to all stocks on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.
- Red zone (bottom 25%): -0.45 or lower
- Yellow zone (middle 50%): -0.45 to 0.96
- Green zone (top 25%): 0.96 or higher
- Top 1%: 4.65+
- Median: 0.10 — half of all investments score higher
How it compares to other similar stocks
The table compares OptimizeRx Corporation's Sharpe Ratio with other stocks in the Health Information Services industry across multiple time periods, showing how OPRX's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jul 11, 2026.
| Symbol | Name | 1Y Sharpe Ratio | 5Y Sharpe Ratio | 10Y Sharpe Ratio | All Time Sharpe Ratio |
|---|---|---|---|---|---|
| BTSG | BrightSpring Health Services, Inc | 6.18 | |||
| BTSGU | BrightSpring Health Services Inc. Tangible Equity Unit | 6.05 | |||
| TXG | 10x Genomics, Inc. | 3.44 | |||
| HNGE | Hinge Health, Inc | 1.67 | |||
| CRVW | Careview Comm Inc | 1.30 | |||
| OMCL | Omnicell, Inc. | 1.06 | |||
| PRVA | Privia Health Group, Inc. | 0.94 | |||
| LGMK | LogicMark Inc | 0.93 | |||
| SOPH | SOPHiA GENETICS SA | 0.77 | |||
| NUTX | Nutex Health Inc | 0.62 | |||
| OPRX | OptimizeRx Corporation | -0.66 |
Loading charts...
How does OPRX fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
Analyze Your Portfolio